Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCV) antigen and antibody status.
The company now exceeds the sector benchmark for its overall ESG rating and for all three measures
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China
Lupin Diagnostics will equip doctors with accurate diagnosis in the patient journey by leveraging innovative technologies
George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies
The FDA's Orphan Drug Designation is granted to investigational therapies addressing rare medical diseases or conditions that affect fewer than 200,000 people
Upgrades and global expansion provide additional control, visibility, reliability and recovery for patient-critical, time-and temperature-sensitive products
Orion to receive an upfront payment of USD 290 million
To strengthen the integrated human-centric preventive health screening ‘Phygital’ ecosystem in India
Mittal will be driving expansion of the provider network across India
Subscribe To Our Newsletter & Stay Updated
